All times are listed in CEST (Central European Summer Time)

Browsing Over 461 Presentations

Sort By
José Baselga: Cancer’s fiercest opponent (ID 49)

Panel discussion (ID 477)

Lecture Time
11:05 - 11:20
Authors
Session Name
José Baselga: Cancer’s fiercest opponent (ID 49)
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
José Baselga: Cancer’s fiercest opponent (ID 49)

Introduction of the documentary (ID 475)

Lecture Time
10:04 - 10:08
Speakers
Authors
Session Name
José Baselga: Cancer’s fiercest opponent (ID 49)
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
José Baselga: Cancer’s fiercest opponent (ID 49)

Documentary (ID 476)

Lecture Time
10:08 - 11:05
Speakers
Authors
Session Name
José Baselga: Cancer’s fiercest opponent (ID 49)
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
José Baselga: Cancer’s fiercest opponent (ID 49)

Welcome address from ESMO (ID 474)

Lecture Time
10:00 - 10:04
Speakers
Authors
Session Name
José Baselga: Cancer’s fiercest opponent (ID 49)
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
AstraZeneca - Controversies in Breast Cancer (ID 48)

Treatment beyond CDK4/6i - what comes next? (ID 471)

Lecture Time
12:00 - 12:15
Speakers
Authors
Session Name
AstraZeneca - Controversies in Breast Cancer (ID 48)
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
Gilead - Triple-Negative Breast Cancer: See Beyond the Negatives (ID 35)

Live Q&A (ID 411)

Lecture Time
11:30 - 11:30
Session Name
Gilead - Triple-Negative Breast Cancer: See Beyond the Negatives (ID 35)
Room
Munich Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
YO “HowTo” Session: How to move genomic profiling to clinical practice by multidisciplinary collaboration? (ID 3)

Clinical case presentation from the molecular tumor board (ID 18)

Lecture Time
11:30 - 11:30
Speakers
Authors
Session Name
YO “HowTo” Session: How to move genomic profiling to clinical practice by multidisciplinary collaboration? (ID 3)
Room
Frankfurt Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
PER-sponsored supported by Sanofi Genzyme - Tumor Board: How the Experts Approach Personalized Care Plans in ER+ BC (ID 5)

Tumor Board 1: Current Management Options for HR+/HER2- Metastatic Breast Cancer (ID 268)

Lecture Time
11:30 - 11:30
Speakers
Authors
Session Name
PER-sponsored supported by Sanofi Genzyme - Tumor Board: How the Experts Approach Personalized Care Plans in ER+ BC (ID 5)
Room
Hamburg Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
AstraZeneca - Controversies in Breast Cancer (ID 48)

Jumping the Gun - Should we wait for OS data in eBC? (ID 469)

Lecture Time
11:30 - 11:45
Speakers
Authors
Session Name
AstraZeneca - Controversies in Breast Cancer (ID 48)
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
Gilead - Triple-Negative Breast Cancer: See Beyond the Negatives (ID 35)

Evolving treatment landscape in TNBC (ID 409)

Lecture Time
11:30 - 11:30
Speakers
Authors
Session Name
Gilead - Triple-Negative Breast Cancer: See Beyond the Negatives (ID 35)
Room
Munich Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
PER-sponsored supported by Sanofi Genzyme - Tumor Board: How the Experts Approach Personalized Care Plans in ER+ BC (ID 5)

Post-session Questions (ID 271)

Lecture Time
12:00 - 12:00
Speakers
Authors
Session Name
PER-sponsored supported by Sanofi Genzyme - Tumor Board: How the Experts Approach Personalized Care Plans in ER+ BC (ID 5)
Room
Hamburg Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
AstraZeneca - Controversies in Breast Cancer (ID 48)

Q&A / discussion (ID 478)

Lecture Time
12:15 - 12:30
Speakers
Authors
Session Name
AstraZeneca - Controversies in Breast Cancer (ID 48)
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30